文献速递母胎医学产科

使用临床医生报告的产前护理遗传检测效用指数(C-GUIDE Prenatal)衡量产前外显子组测序的效用:一项回顾性多中心研究

Measuring the Utility of Prenatal Exome Sequencing Using the Clinician-Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study.
PubMed 文献 · Prenat Diagn · 2026-11-11

该回顾性多中心研究在加拿大安大略省5家诊所纳入115例符合产前外显子组测序(ES)标准的妊娠病例,使用C-GUIDE Prenatal评估ES的临床效用。结果显示诊断率为41.7%,平均C-GUIDE Prenatal评分为9.48(SD 11.51);与阴性结果相比,有信息量的阳性结果使评分增加17.6(p<0.001);与满足1条ES标准相比,满足≥3条标准使评分增加3.8(p<0.05);与结果披露时妊娠未继续相比,妊娠继续使评分增加2.8(p<0.001)。

要点

  • 产前ES在115例队列中诊断率为41.7%,平均C-GUIDE Prenatal评分为9.48(SD 11.51)。
  • 有信息量的阳性结果较阴性结果使C-GUIDE Prenatal评分增加17.6(p<0.001)。
  • 满足≥3条ES标准较满足1条标准使评分增加3.8(p<0.05);妊娠继续较未继续使评分增加2.8(p<0.001)。

核心结论

  • 研究结果填补了产前遗传检测临床价值证据库中的知识空白,该证据库用于指导产前遗传检测的政策与资助决策。

研究设计与样本

  • 回顾性多中心研究,在加拿大安大略省5家诊所识别符合产前ES标准的病例。
  • 共纳入115例病例,临床医生使用C-GUIDE Prenatal评估ES的效用。
  • 采用描述性方法总结病例特征,计算C-GUIDE Prenatal总分并使用广义估计方程对临床重要变量进行回归分析。

主要发现

  • 115例病例中,诊断率为41.7%。
  • C-GUIDE Prenatal平均评分为9.48(SD 11.51)。
  • 与阴性结果相比,有信息量的阳性结果与C-GUIDE Prenatal评分增加17.6相关(p<0.001)。
  • 与满足1条ES标准相比,满足≥3条标准与C-GUIDE Prenatal评分增加3.8相关(p<0.05)。
  • 与结果披露时妊娠未继续相比,妊娠继续与C-GUIDE Prenatal评分增加2.8相关(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the diagnostic and clinical utility of prenatal exome sequencing (ES) in a cohort of pregnancies using the Clinician-reported Genetic testing Utility InDEx for Prenatal Care (C-GUIDE Prenatal). METHODS: Cases that met criteria for prenatal ES in Ontario, Canada were identified in 5 clinics. Clinicians assessed the utility of ES using C-GUIDE Prenatal, a clinician-reported measure of how genetic testing informs pregnancy and neonatal management. Case characteristics were summarized descriptively. C-GUIDE Prenatal total scores were calculated and regressed against clinically important variables using generalised estimating equations. RESULTS: Among 115 cases, the diagnostic yield was 41.7%. The mean C-GUIDE Prenatal score was 9.48 (SD 11.51). Compared with negative results, informative positive results were associated with an increase in C-GUIDE Prenatal score of 17.6 (p < 0.001). Compared to meeting one criterion for ES, meeting ≥ 3 criteria was associated with an increase in C-GUIDE Prenatal score of 3.8 (p < 0.05). Compared with pregnancies that were not ongoing at result disclosure, ongoing pregnancy was associated with an increase in the C-GUIDE Prenatal score of 2.8 (p < 0.001). CONCLUSION: Findings address a knowledge gap in the clinical value evidence base that informs policy and funding decision-making for prenatal genetic testing.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Hayeems RZ, Luca S, Xiao B, et al. Measuring the Utility of Prenatal Exome Sequencing Using the Clinician-Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study. Prenat Diagn. 2026. PMID: 43013894. doi:10.1002/pd.70306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。